Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial (Q73480165)
Jump to navigation
Jump to search
scientific article published on 01 June 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial |
scientific article published on 01 June 2003 |
Statements
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial (English)
W J Sandborn
B E Sands
D C Wolf
J F Valentine
M Safdi
S Katz
K L Isaacs
L D Wruble
J Katz
D H Present
F Graeme-Cook
D J Odenheimer
1 reference
1 reference
1 reference
1 reference